CompletedNot applicableNCT03451487
A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study
Studying Paracetamol poisoning
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sinew Pharma Inc.
- Principal Investigator
- TeYu Mr Lin, Dr.Principal Investigator
- Intervention
- Panadol®(drug)
- Enrollment
- 28 enrolled
- Eligibility
- 20-50 years · All sexes
- Timeline
- 2022 – 2022
Study locations (1)
- Tri-Service General Hospital, Taipei, Neihu District, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03451487 on ClinicalTrials.govOther trials for Paracetamol poisoning
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06549062Pharmacokinetics and Pharmacodynamics of Intravenous Paracetamol in Morbidly Obese and Non- Obese Patients.University Hospital, Ghent
- RECRUITINGNCT04964310Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control StudyThe First Affiliated Hospital with Nanjing Medical University